INGENIO
Report
- Report Number
- 2124215-2012-16455
- Event Type
- Malfunction
- Date Received
- January 11, 2013
- Date of Event
- November 17, 2012
- Report Date
- November 17, 2012
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- NVZ
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- AL
- Reporter Occupation
- HEALTH PROFESSIONAL
Narratives
ADDITIONAL INFORMATION HAS BEEN REQUESTED. HOWEVER, AT THIS TIME THERE IS NO FURTHER INFORMATION AVAILABLE. IF ADDITIONAL INFORMATION BECOMES AVAILABLE THIS REPORT WILL BE UPDATED.
ADDITIONAL INFORMATION RECEIVED FROM THE LOCAL AREA SALES REPRESENTATIVE INDICATED THAT THE ROOT CAUSE TO THE ISSUE WAS NEVER DETERMINED. THE RESULTS OF THE CHEST X-RAY INDICATED APPROPRIATE LEAD POSITION. THE SALES REPRESENTATIVE HAS NOT RECEIVED ANY FOLLOW UP CALLS FROM THE PHYSICIAN NOR THE PHYSICIAN'S OFFICE OUTLINING ANY CONCERNS REGARDING THIS PATIENT. THE PATIENT WAS ADVISED TO CONTACT THEIR PHYSICIAN IF THERE WERE EVER ANY ISSUES. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
--
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT ONE DAY POST IMPLANT THE PATIENT WITH THIS PACEMAKER EXPERIENCED A DECREASE IN THEIR HEART RATE TO 29-35 BEATS PER MINUTE (BPM) INTERMITTENTLY FOR APPROXIMATELY FORTY FIVE MINUTES. THE PATIENT WAS REPORTEDLY LYING FLAT ON THEIR BACK WHEN IT OCCURRED. IT HAD BEEN REPORTED THAT THE PATIENT WENT INTO COMPLETE HEART BLOCK DURING THE IMPLANT PROCEDURE. ALL PACING IMPEDANCE AND THRESHOLD MEASUREMENTS WERE TESTED AND WITHIN NORMAL LIMITS. VENTRICULAR TACHYCARDIA (VT) STORAGE IN THE DEVICE WAS ON AND THERE WERE NO EPISODES STORED IN THE ARRHYTHMIA LOGBOOK. HOWEVER, THERE WERE 247 PREMATURE VENTRICULAR CONTRACTIONS (PVC) AND THE PATIENT'S RATE COUNT WAS AS LOW AS 50-59 BPM TO AS HIGH AS 240-249 BPM. A BOSTON SCIENTIFIC TECHNICAL SERVICES CONSULTANT DISCUSSED THE ISSUE MAY BE RELATED TO THE PVC'S, LOSS OF CAPTURE (LOC), OR OVERSENSING OF NOISE. THE POSITION OF THE NEWLY IMPLANTED LEAD WAS ALSO IN QUESTION. THE LOCAL AREA SALES REPRESENTATIVE PLANNED TO DECREASE THE SENSITIVITY TO 3 MV AND OBTAIN A CHEST X-RAY. AT THIS TIME THE ROOT CAUSE OF THE ISSUE IS UNKNOWN. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 17245 | INGENIO | IMPLANTABLE PULSE GENERATOR | NVZ | GUIDANT CRM CLONMEL IRELAND | K063 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 82 YR | 4136| 4135| K063 |